Search bioRxiv⌕ Search

Biology subjects

Levin, H.

Publications and source records attributed to Levin, H..

2 recordsLinked to original sources

Increased EV yield and bioactivity of matrix-bound nanovesicles compared to conditioned culture medium-derived extracellular vesicles

Aim: Extracellular vesicles (EVs) are nanoparticles secreted by cells for cell-cell communication functions, such as wound repair, but low yields often limit their use. Several isolation methods have been explored to increase EV yield from conditioned culture medium (liquid-EVs); however, few studies compare isolation techniques and yield between liquid-EVs and matrix-bound nanovesicles (MBVs), a novel EV subtype embedded within the extracellular matrix. Methods: We isolate liquid-EVs and MBVs from mesenchymal stem cells (MSC) using size exclusion chromatography (SEC) and ultracentrifugation (UC) across various timepoints (14, 21, 24, 30 days). EVs are characterized by their yield, size, morphology, protein concentration, surface marker expression (CD9, CD81, ALIX), zeta potential, and influence on fibroblast wound closure. Results: We find that isolation method influences yield, where both SEC isolated liquid-EVs and MBVs yield higher particle counts and protein compared to UC. Interestingly, we find that regardless of isolation method, MBVs have a significantly higher yield than liquid-EVs from the same culture (15.6-fold higher using UC and 7.49-fold higher using SEC). Culturing for 24 days yielded the greatest number of MBV particles and protein. We performed a fibroblast scratch assay to assess bioactivity and found that liquid-EVs decreased wound closure compared to a medium control, whereas MBVs did not. Conclusion: Our work suggests SEC maximizes particle and protein yields for MSC-EVs. By achieving much higher yields of MBVs compared to liquid-EVs, and their promise as a wound repair strategy, we offer an alternative EV choice when EV yields are an issue towards translation.

bioengineering↗

Functional characterization of the 9q34.13 locus identifies RAPGEF1 as modulating risk for melanoma and nevi via RAS activation

Genome-wide association studies identified a melanoma- and nevus count-associated locus on chromosome band 9q34.13. Fine-mapping and melanocyte expression data collectively suggest two potential causal genes with opposite association with risk: higher levels of Rap guanine nucleotide exchange factor 1 (RAPGEF1) and lower levels of uridine-cytidine kinase 1 (UCK1). Colocalization analyses and conditional TWAS suggest multiple causal cis-regulatory sequence variants in partial linkage disequilibrium (LD) to each other. Melanocyte capture-HiC and CRISPR-inhibition demonstrated regulatory interactions between fine-mapped variants and the RAPGEF1 and UCK1 promoters. Focusing on RAPGEF1, we demonstrate RAPGEF1 expression promotes melanocyte growth and drives malignant transformation of human immortalized melanocytes. Following treatment with human EGF, RAPGEF1 overexpression activated both RAP1 and RAS. Further, we show RAPGEF1 expression is significantly enriched in melanomas lacking strongly activating RAS-MAPK mutations, suggesting that RAPGEF1 may promote oncogenic RAS-MAPK signaling in melanomas. Furthermore, in these tumors, we provide preliminary evidence to support the prognostic relevance of RAPGEF1 expression in patients lacking RAS or BRAF mutations. Together with other recent studies, these data suggest that germline variation influencing RAS activation may play a key role in nevus development and melanoma risk.

genetics↗